Concepedia

Publication | Open Access

High Virulence and Antifungal Resistance in Clinical Strains of<i>Candida albicans</i>

43

Citations

37

References

2016

Year

Abstract

Antifungal resistance and virulence properties of <i>Candida albicans</i> are a growing health problem worldwide. To study the expression of virulence and azole resistance genes in 39 clinical strains of <i>C. albicans</i>, we used a model of infection of human vaginal epithelial cells with <i>C. albicans</i> strains isolated from Mexican women with vulvovaginal candidiasis (VVC). The strains were identified by PCR amplification of the ITS1 and ITS2 regions of rRNA. The detection and expression of virulence genes and azole resistance genes <i>MDR1</i> and <i>CDR1</i> were performed using PCR and RT-PCR, respectively. All strains were sensitive to nystatin and 38 (97.4%) and 37 (94.9%) were resistant to ketoconazole and fluconazole, respectively. <i>ALS1</i>, <i>SAP4-SAP6</i>, <i>LIP1</i>, <i>LIP2</i>, <i>LIP4</i>, <i>LIP6</i>, <i>LIP7</i>, <i>LIP9</i>, <i>LIP10</i>, and <i>PLB1</i>-<i>PLB2</i> were present in all strains; <i>SAP1</i> was identified in 37 (94.8%) isolates, <i>HWP1</i> in 35 (89.7%), <i>ALS3</i> in 14 (35.8%), and <i>CDR1</i> in 26 (66.6%). In nearly all of the strains, <i>ALS1</i>, <i>HWP1</i>, <i>SAP4-SAP6</i>, <i>LIP1-LIP10</i>, <i>PLB1</i>, and <i>PLB2</i> were expressed, whereas <i>CDR1</i> was expressed in 20 (51.3%) and <i>ALS3</i> in 14 (35.8%). In our in vitro model of infection with <i>C. albicans</i>, the clinical strains showed different expression profiles of virulence genes in association with the azole resistance gene <i>CDR1</i>. The results indicate that the strains that infect Mexican patients suffering from VVC are highly virulent and virtually all are insensitive to azoles.

References

YearCitations

Page 1